Please login to the form below

Envision Pharma Group appoints new CEO

Meg Heim named as its new Chief Executive Officer

London, UK (Sept. 22, 2022)

Envision Pharma Group is pleased to announce the appointment of Meg Heim as its new Chief Executive Officer. Meg is an accomplished business leader with strong leadership experience, and an established reputation within Pharmaceutical, Medical Device and Health Technology markets. Throughout her career she has championed the professionalism of medical affairs and the innovations that improve patient experience.

Working closely with a strong and experienced Executive Leadership Team, Meg will be responsible for delivering an ambitious five-year plan that will reinforce Envision as the global leader in scientific and commercialization strategy and solutions; medical affairs; and lifecycle planning enabled by leading technology solutions and world-class people.

Meg joins Envision at a pivotal moment, with Group performance accelerating as it continues to deliver a compelling combination of technology and services to clients. Envision’s strategy and innovation has ensured the company continues to serve and anticipate its clients’ evolving needs. Meg replaces David Thompson, who steps down as CEO to pursue other opportunities, including in the not-for-profit sector at a cancer charity, after more than six years with Envision Pharma Group and over 25 years in the industry.

Brian Hepburn Executive Co-Chair of Envision Pharma Group said: “I am truly excited by the appointment of Meg as our new Chief Executive Officer. Meg has an established track record within the healthcare industry and brings with her a deep understanding of medical affairs which will be highly complementary to the existing expertise within the business. This is an exciting time for Envision as we continue to accelerate innovation and work towards our vision of improving lives through the power of our technology and expertise.”

Meg said: “I am energized to be joining Envision Pharma Group at such an important time in the industry. I see a clear opportunity for further growth building off established and new opportunities in the sector. The company has an exceptional team and client base, and I am looking forward to spending time with our people, our clients, and other key partners.”

--Ends--

About Envision Pharma Group
Founded in 2001, Envision Pharma Group is a global, technology-enabled scientific communications company serving pharmaceutical, biotechnology, and medical device companies. As a leading provider of evidence-based communication services and industry-leading technology solutions (iEnvision) that have applicability across many areas of medical affairs and related functional responsibility, Envision provides scientific communication services and technology solutions to more than 90 companies, including 19 of the top 20 pharmaceutical companies. Learn more at:www.envisionpharmagroup.com.

23rd September 2022

Share

Tags

Company Details

Envision Pharma Group

01403 322 000

Contact Website

Address:
Envision House
5 North Street
Horsham
West Sussex
RH12 1XQ
England

Latest content on this profile

Envision Pharma Group and Alucio™ partner to power next-generation scientific exchange for the life science industry
Collaboration capitalizes on Alucio’s flagship Beacon platform and Envision’s global leadership in medical strategy and healthcare communications
Envision Pharma Group
Envision Pharma Group appoints Head of Envision Value & Access
Envision Pharma Group is pleased to announce the appointment of Mel Formica as its Head of Envision Value & Access.
Envision Pharma Group
Envision Pharma Group appoints new CEO
Meg Heim named as its new Chief Executive Officer
Envision Pharma Group
Envision Pharma Group partners with scite to display Smart Citations in iEnvision® – the global medical affairs platform
Smart Citations will feature in Library, Datavision®, and Scientific Communication Platform modules
Envision Pharma Group
Envision Pharma Group expands capabilities with specialist behavioral science offering Envision the Change

Envision Pharma Group
Envision Pharma Group and Vitaccess create a global partnership to power evidence generation for the biopharmaceutical industry
Move combines Envision’s global leadership position in medical affairs communications with Vitaccess’ award-winning capabilities in real-world evidence (RWE)
Envision Pharma Group